Sun Pharma Debenture

India's Sun Pharmaceuticals to consider raising $1.55 billion via debentures

Sun Pharmaceuticals plans to raise up to 150 billion rupees ($1.55 billion) through non-convertible debentures, subject to approval at its October 12 board meeting.